Lynx Therapeutics Overview
Update this profile
Lynx Therapeutics General Information
Developer of genetic analysis technologies for pharmaceutical, biotechnology and agricultural industries. The company's cloning and sequencing technologies provide comprehensive and quantitative digital gene expression data which is important to systems biology research enabling drug discovery and development companies to research, develop and implement new treatments for improving human health.
Want to dig into this profile?
We’ll help you find what you need
Lynx Therapeutics Valuation & Funding
Lynx Therapeutics Patents
Applications and Grants
000 Total Patents
in next 12 mo
Lynx Therapeutics Recent Patent Activity
First Filing Date
Method for detecting foreign dna in a host genome
Using fluorescent activated cell sorting to identify cells comprising heterologous nucleotide sequences; disease resistant plants; tissue engineering
Includes a patterned seal having a specified arrangement of holes and groves, and an connection plate having passages corresponding to the holes in the seal.
Modulating phenotypes; genetic engineering; adjust cholesterol concentration in blood
A set of polynucleotide sequences that are differentially regulated in response to cholesterol and adipogenesis
To view Lynx Therapeutics’s complete patent history, request access »
Lynx Therapeutics Former Investors